The Phosphodiesterase 4 Inhibitor Roflumilast as an Adjunct to Antidepressants in Major Depressive Disorder Patients

NCT04751071 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Institutional and funding constrains

Conditions

Major Depressive Disorder

Interventions

DRUG: Roflumilast 500Mcg Tab
DRUG: Placebo

Sponsor

Sadat City University